Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology?: A comparative study in lung and gastrointestinal tract cancer

被引:17
作者
Lonneux, M [1 ]
Delval, D [1 ]
Bausart, R [1 ]
Moens, R [1 ]
Willockx, R [1 ]
Van Mael, P [1 ]
Declerck, P [1 ]
Jamar, F [1 ]
Zreik, H [1 ]
Pauwels, S [1 ]
机构
[1] Catholic Univ Louvain, Sch Med, Ctr Nucl Med, B-1200 Brussels, Belgium
关键词
D O I
10.1097/00006231-199811000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In this study, we prospectively compared the sensitivity of PET and planar SPET (collimated gamma camera) F-18-FDG imaging in patients with lung and gastrointestinal tract cancer and analysed their respective impact on patient management. Twenty-eight patients with lung cancer and 14 with gastrointestinal tract tumours were scanned on the same day with a PET and a collimated planar SPET gamma camera. The planar SPET procedure consisted of whole-body planar views and a tomographic acquisition centred over the torso or the abdomen, with the total imaging time within the same range as the whole-body PET procedure. The staging of lung cancer patients was accurate in 86% with PET and 64% with planar SPET. Planar SPET would have led to inappropriate therapeutic decisons in 8 of 28 patients, mainly due to undectected distant metastases. In patients with suspected gastrointestinal tract cancer, planar SPET identified 7 of 15 (47%) proven tumour sites, whereas PET identified 14 of 15 (93%). Our results suggest that collimated planar SPET cameras are not a substitute for dedicated PET scanners. The sensitivity for the detection of tumours is unacceptably low and can impair patient management. The use of multiple tomographic acquisitions could improve the sensitivity but would require a longer scanning time. ((C) 1998 Lippincott Williams & Wilkins).
引用
收藏
页码:1047 / 1054
页数:8
相关论文
共 22 条
  • [1] Axillary lymph node metastases: Screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET
    Adler, LP
    Faulhaber, PF
    Schnur, KC
    AlKasi, NL
    Shenk, RR
    [J]. RADIOLOGY, 1997, 203 (02) : 323 - 327
  • [2] EVALUATION OF BREAST MASSES AND AXILLARY LYMPH-NODES WITH [F-18] 2-DEOXY-2-FLUORO-D-GLUCOSE PET
    ADLER, LP
    CROWE, JP
    ALKAISI, NK
    SUNSHINE, JL
    [J]. RADIOLOGY, 1993, 187 (03) : 743 - 750
  • [3] Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses
    Anzai, Y
    Carroll, WR
    Quint, DJ
    Bradford, CR
    Minoshima, S
    Wolf, GT
    Wahl, RL
    [J]. RADIOLOGY, 1996, 200 (01) : 135 - 141
  • [4] CLINICAL-VALUE OF WHOLE-BODY POSITRON EMISSION TOMOGRAPHY WITH [F-18] FLUORODEOXYGLUCOSE IN RECURRENT COLORECTAL-CANCER
    BEETS, G
    PENNINCKX, F
    SCHIEPERS, C
    FILEZ, L
    MORTELMANS, L
    KERREMANS, R
    AERTS, R
    DEROO, M
    [J]. BRITISH JOURNAL OF SURGERY, 1994, 81 (11) : 1666 - 1670
  • [5] TECHNOLOGY FOR FDG SPECT WITH A RELATIVELY INEXPENSIVE GAMMA-CAMERA - WORK-IN-PROGRESS
    DRANE, WE
    ABBOTT, FD
    NICOLE, MW
    MASTIN, ST
    KUPERUS, JH
    [J]. RADIOLOGY, 1994, 191 (02) : 461 - 465
  • [6] DIAGNOSIS OF PANCREATIC-CANCER BY 2[F-18]-FLUORO-2-DEOXY-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY
    FRIESS, H
    LANGHANS, J
    EBERT, M
    BEGER, HG
    STOLLFUSS, J
    RESKE, SN
    BUCHLER, MW
    [J]. GUT, 1995, 36 (05) : 771 - 777
  • [7] Lymph node staging in non-small cell lung cancer: Evaluation by [F-18]FDG positron emission tomography (PET)
    Guhlmann, A
    Storck, M
    Kotzerke, J
    Moog, F
    SunderPlassmann, L
    Reske, SN
    [J]. THORAX, 1997, 52 (05) : 438 - 441
  • [8] Holle LH, 1996, J NUCL MED, V37, P615
  • [9] HUBNER KF, 1995, CLIN NUCL MED, V20, P293
  • [10] DIAGNOSIS OF RECURRENT BRAIN-TUMOR - VALUE OF (TI)-T-201 SPECT VS F-18 FLUORODEOXYGLUCOSE PET
    KAHN, D
    FOLLETT, KA
    BUSHNELL, DL
    NATHAN, MA
    PIPER, JG
    MADSEN, M
    KIRCHNER, PT
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 163 (06) : 1459 - 1465